Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Non-Current Assets: 2016-2025

Historic Non-Current Assets for Tg Therapeutics (TGTX) over the last 10 years, with Sep 2025 value amounting to $425.3 million.

  • Tg Therapeutics' Non-Current Assets rose 3460.14% to $425.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $425.3 million, marking a year-over-year increase of 3460.14%. This contributed to the annual value of $11.3 million for FY2024, which is 2.69% down from last year.
  • Per Tg Therapeutics' latest filing, its Non-Current Assets stood at $425.3 million for Q3 2025, which was up 1,000.25% from $38.7 million recorded in Q2 2025.
  • Over the past 5 years, Tg Therapeutics' Non-Current Assets peaked at $425.3 million during Q3 2025, and registered a low of $11.3 million during Q4 2024.
  • In the last 3 years, Tg Therapeutics' Non-Current Assets had a median value of $12.2 million in 2025 and averaged $52.1 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first slumped by 79.32% in 2023, then surged by 3,460.14% in 2025.
  • Tg Therapeutics' Non-Current Assets (Quarterly) stood at $48.7 million in 2021, then crashed by 48.01% to $25.3 million in 2022, then slumped by 53.97% to $11.6 million in 2023, then decreased by 2.69% to $11.3 million in 2024, then surged by 3,460.14% to $425.3 million in 2025.
  • Its Non-Current Assets stands at $425.3 million for Q3 2025, versus $38.7 million for Q2 2025 and $12.2 million for Q1 2025.